Search research articles
Contact Us
Filters
Showing results (821-830 of 839) with videos related to
Page
of 84
Sort By:
Clinical Lung Cancer
|
October 25, 2023
Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non-Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201)
Jia-Tao Zhang, Song Dong, Wei-Quan Gu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2020
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial
Wen-Zhao Zhong, Qun Wang, Wei-Min Mao, et al.
Antimicrobial Agents and Chemotherapy
|
May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis Treatment
Eric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, et al.
Acta Neuropathologica Communications
|
September 17, 2024
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors
Richard A Hickman, Alexandra M Miller, Bridget M Holle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 19, 2026
LAMPAD:An Integrated ctDNA-Based Model for Predicting Potential Cure in Resected NSCLC Patients
Jia-Tao Zhang, Ke-Zhong Chen, Xuan Gao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
Si-Yang Liu, Tatiana Erazo, Justin Jee, et al.
Cell Reports
|
August 8, 2024
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC
Yang-Si Li, Wen-Pu Lai, Kai Yin, et al.
Nature Medicine
|
July 24, 2023
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
Si-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases
Yang-Si Li, Wenpu Lai, Kai Yin, et al.
NPJ Vaccines
|
February 29, 2024
Immune persistence after different polio sequential immunization schedules in Chinese infants
Ting Zhao, Jing Li, Teng Huang, et al.
Page
of 84
Search research articles
Search
Showing results (821-830 of 839) with videos related to
Sort By:
Page
of 84
Clinical Lung Cancer
|
October 25, 2023
Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non-Small-Cell Lung Cancer Patients After Radical Resection Based on Longitudinal Undetectable Molecular Residual Disease: Prospective, Multicenter, Single-Arm Study (CTONG 2201)
Jia-Tao Zhang, Song Dong, Wei-Quan Gu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 17, 2020
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial
Wen-Zhao Zhong, Qun Wang, Wei-Min Mao, et al.
Antimicrobial Agents and Chemotherapy
|
May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis Treatment
Eric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, et al.
Acta Neuropathologica Communications
|
September 17, 2024
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumors
Richard A Hickman, Alexandra M Miller, Bridget M Holle, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 19, 2026
LAMPAD:An Integrated ctDNA-Based Model for Predicting Potential Cure in Resected NSCLC Patients
Jia-Tao Zhang, Ke-Zhong Chen, Xuan Gao, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2024
Optimal systemic treatment and real-world clinical application of ctDNA in patients with metastatic HER2-mutant lung cancer
Si-Yang Liu, Tatiana Erazo, Justin Jee, et al.
Cell Reports
|
August 8, 2024
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLC
Yang-Si Li, Wen-Pu Lai, Kai Yin, et al.
Nature Medicine
|
July 24, 2023
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial
Si-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, et al.
Journal for Immunotherapy of Cancer
|
November 28, 2025
Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases
Yang-Si Li, Wenpu Lai, Kai Yin, et al.
NPJ Vaccines
|
February 29, 2024
Immune persistence after different polio sequential immunization schedules in Chinese infants
Ting Zhao, Jing Li, Teng Huang, et al.
Page
of 84